NEW RESEARCH: Updated Executive Informational Overview for AtheroNova Inc. (AHRO) We released a new report today--an Updated Executive Informational Overview--on AtheroNova Inc. (AHRO-OTC). ... Laura Swartz January 22, 2014 at 12:32 PM
AtheroNova Announces Phase I Enrollment Complete for Clinical Trial of AHRO-001 in Treating Atherosclerosis AtheroNova Inc. announced today a significant milestone in completing the active treatment portion of its ... Karen Goldfarb December 5, 2013 at 1:14 PM
AtheroNova Announces New Member of Clinical Advisory Board Karen Goldfarb October 15, 2013 at 1:28 PM
FULL VIDEO (Reuters TV): Biotech Stocks To Watch and More Last week, Jeff Kraws sat down with Rhonda Schaffler at Reuters to discuss opportunities and trends in the ... Colleen Koski August 15, 2013 at 1:25 PM
Russian Biotech Sector is Good News for U.S. Companies An article published last week on FierceBiotech described Russia's current biotech focus and the ... Laura Swartz July 22, 2013 at 2:05 PM
AtheroNova Initiates Phase I Trial of AHRO-001 Today, AtheroNova Inc. (AHRO-OTC) announced that it has initiated a Phase I clinical trial with AHRO-001, the ... Colleen Koski June 25, 2013 at 12:50 PM
AtheroNova Reaches Major Milestone: Starts Phase I in June Yesterday, AtheroNova Inc. (AHRO-OTC) announced a major milestone in the Company's progression to Phase I ... Laura Swartz May 31, 2013 at 11:08 AM
AHRO Nears its Phase I Start with Appointment of Clinical Chair This morning, AtheroNova Inc. (AHRO-OTC) announced that it expanded its clinical expertise by adding Dr. ... Laura Swartz April 11, 2013 at 11:13 AM
April 2013 Quarterly Update and Business Review on AtheroNova (AHRO) Laura Swartz April 5, 2013 at 3:08 PM
NEW RESEARCH: Quarterly Update on AtheroNova Inc. Crystal Research Associates has released a Quarterly Update on AtheroNova Inc., a biotechnology company ... Colleen Koski February 1, 2013 at 10:51 AM
QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Prepares for Phase I Trials This morning, we issued a Quarterly Update on AtheroNova Inc. (AHRO-OTC.BB), a development-stage biotech ... Laura Swartz October 19, 2012 at 9:34 AM
AtheroNova Completes $2.9 Million Private Placement of Common Stock Biotech company AtheroNova Inc. (AHRO-OTC) this morning announced that it raised over $2.9 million in gross ... Laura Swartz October 11, 2012 at 10:30 AM
QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Receives Key Patent Allowance Novel biotech company AtheroNova Inc. (AHRO-OTC) made a significant news announcement last week when it ... Laura Swartz July 16, 2012 at 4:27 PM
NEW RESEARCH: AtheroNova (AHRO-OTC) Works to Unclog Your Arteries New research available in our library at www.crystalra.com gives readers a complete description of the ... Laura Swartz June 6, 2012 at 10:25 AM